Drug factory · FDA FEI 3002806806

Chemo Biosynthesis s.r.l.

Via per Voghera 1, Corana, Italy

Italy: 1

Problems found, fixed voluntarily at FDA's last inspection, Feb 5, 2026.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2011: 0 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AbirateroneMakes the active ingredient Caraco Pharmaceutical Laboratories, Ltd. 47335-401

FDA inspection history

EndedResultProgramProblems noted
Feb 5, 2026Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 26, 2021Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 15, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.